Current through Register 1531, September 27, 2024
Fluoroscopic X-ray Systems shall be installed and maintained
to comply with the Federal Performance Standard for Fluoroscopic Equipment,
21 CFR
1020.32 and shall also meet the following
requirements except
21 CFR
1020.32 shall prevail should there be a
conflict.
(A)
Limitation
of Useful Beam.
(1)
Primary Barrier.
(a)
The fluoroscopic imaging assembly shall be provided with a primary protective
barrier which intercepts the entire cross section of the useful beam at any
SID.
(b) The x-ray tube used for
fluoroscopy shall not produce x-rays unless the barrier is in position to
intercept the entire useful beam.
(c) Radiation therapy simulation systems
shall be exempt from 105 CMR 120.405(A) provided the systems are intended only
for remote control operation.
(2)
Fluoroscopic Beam
Limitation.
(a) For certified
fluoroscopic systems with or without a spot film device, neither the length nor
the width of the x-ray field in the plane of the image receptor shall exceed
that of the visible area of the image receptor by more than 3% of the SID. The
sum of the excess length and the excess width shall be no greater than 4% of
the SID.
(b) For uncertified
fluoroscopic systems with a spot film device, the x-ray beam with the shutters
fully opened (during fluoroscopy or spot filming) shall be no larger than the
largest spot film size for which the device is designed. Measurements shall be
made at the minimum SID available but at no less than 20 centimeters table top
to the film plane distance.
(c) For
uncertified fluoroscopic systems without a spot film device, the requirements
of 120.405(A)(2)(a) apply.
1. Means shall be
provided to permit further limitation of the field. Beam-limiting devices
manufactured after May 22, 1979, and incorporated in equipment with a variable
SID and/or a visible area of greater than 300 square centimeters shall be
provided with means for stepless adjustment of the x-ray field;
2. All equipment with a fixed SID and a
visible area of 300 square centimeters or less shall be provided with either
stepless adjustment of the x-ray field or with means to further limit the x-ray
field size at the plane of the image receptor to 125 square centimeters or
less;
3. If provided, stepless
adjustment shall, at the greatest SID, provide continuous field sizes from the
maximum attainable to a field size of five centimeters by five centimeters or
less;
4. For equipment manufactured
after February 25, 1978, when the angle between the image receptor and beam
axis is variable, means shall be provided to indicate when the axis of the
x-ray beam is perpendicular to the plane of the image receptor; and,
5. For rectangular x-ray fields used with
circular image receptors, the error in alignment shall be determined along the
length and width dimensions of the x-ray field which pass through the center of
the visible area of the image receptor.
(d) For fluoroscopic equipment manufactured
on or after June 10, 2006, other than radiation simulation systems, the maximum
area of the x-ray field in the plane of the image receptor shall conform with
one of the following requirements:
1. When any
linear dimension of the visible area of the image receptor measured through the
center of the visible area is less than or equal to 34 cm in any direction, at
least 80% of the area of the x-ray field overlaps the visible area of the image
receptor; or
2. When any linear
dimension of the visible area of the image receptor measured through the center
of the visible area is greater than 34 cm in any direction, the x-ray field
measured along the direction of greatest misalignment with the visible area of
the image receptor does not extend beyond the edge of the visible area of the
image receptor by more than two cm.
(3)
Spot-film Beam
limitation. Spot-film devices shall meet the following
requirements:
(a) Means shall be provided
between the source and the patient for adjustment of the x-ray field size in
the plane of the film to the size of that portion of the film which has been
selected on the spot film selector. Such adjustment shall be automatically
accomplished except when the x-ray field size in the plane of the film is
smaller than that of the selected portion of the film. For spot film devices
manufactured after June 21, 1979, if the x-ray field size is less than the size
of the selected portion of the film, the means for adjustment of the field size
shall be only at the operator's option;
(b) Neither the length nor the width of the
x-ray field in the plane of the image receptor shall differ from the
corresponding dimensions of the selected portion of the image receptor by more
than 3% of the SID when adjusted for full coverage of the selected portion of
the image receptor. The sum, without regard to sign, of the length and width
differences shall not exceed 4% of the SID;
(c) It shall be possible to adjust the x-ray
field size in the plane of the film to a size smaller than the selected portion
of the film. The minimum field size at the greatest SID shall be equal to, or
less than, five centimeters by five centimeters;
(d) The center of the x-ray field in the
plane of the film shall be aligned with the center of the selected portion of
the film to within 2% of the SID; and,
(e) On spot-film devices manufactured after
February 25, 1978, if the angle between the plane of the image receptor and
beam axis is variable, means shall be provided to indicate when the axis of the
x-ray beam is perpendicular to the plane of the image receptor, and compliance
shall be determined with the beam axis indicated to be perpendicular to the
plane of the image receptor.
(4)
Override. If a
means exists to override any of the automatic x-ray field size adjustments
required in 105 CMR 120.405(A)(2), that means:
(a) Shall be designed for use only in the
event of system failure;
(b) Shall
incorporate a signal visible at the fluoroscopist's position which will
indicate whenever the automatic field size adjustment is overridden;
and,
(c) Shall be clearly and
durably labeled as follows:
FOR X-RAY FIELD
LIMITATION SYSTEM FAILURE
(B)
Activation of the
Fluoroscopic Tube. X-ray production in the fluoroscopic mode shall
be controlled by a device which requires continuous pressure by the
fluoroscopist for the entire time of any exposure. When recording serial
fluoroscopic images, the fluoroscopist shall be able to terminate the x-ray
exposure(s) at any time, but means may be provided to permit completion of any
single exposure of the series in process.
(C)
Air Kerma Rates
.
(1)
Fluoroscopic Equipment
Manufactured Before May 19, 1995.
(a) Fluoroscopic equipment which is provided
with automatic exposure rate control shall not be operable at any combination
of tube potential and current which will result in AKR in excess of 88 mGy per
minute (ten roentgens) per minute at the point where the center of the useful
beam enters the patient, except:
1. During
recording of fluoroscopic images; or
2. When provided with optional high level
control, the equipment shall not be operable at any combination of tube
potential and current which will result in an AKR in excess of ten roentgens
(88 mGy) per minute at the point where the center of the useful beam enters the
patient unless the high level control is activated. Special means of activation
of high level controls shall be required. The high level control shall only be
operable when continuous manual activation is provided by the operator. A
continuous signal audible to the fluoroscopist shall indicate that the high
level control is being employed.
(b) Fluoroscopic equipment which is not
provided with automatic exposure rate control shall not be operable at any
combination of tube potential and current which will result in AKR in excess of
44 mGy (five roentgens) per minute at the point where the center of the useful
beam enters the patient, except:
1. During
recording of fluoroscopic images; or
2. When an optional high level control is
activated. Special means of activation of high level controls shall be
required. The high level control shall only be operable when continuous manual
activation is provided by the operator. A continuous signal audible to the
fluoroscopist shall indicate that the high level control is being
employed.
(c)
Fluoroscopic equipment which is provided with both automatic exposure rate
control mode and a manual mode shall not be operable at any combination of tube
potential and current which shall result in an AKR in excess of 88 mGy (ten
roentgens) per minute in either mode at the point where the center of the
useful beam enters the patient, except:
1.
During recording of fluoroscopic images; or
2. When the mode or modes have an optional
high level control, in which case that mode or modes shall not be operable at
any combination of tube potential and current which shall result in an AKR in
excess of 88 mGy (ten roentgens) per minute at the point where the center of
the useful beam enters the patient, unless high level control is activated.
Special means of activation of high level controls shall be required. The high
level control shall only be operable when continuous manual activation is
provided by the operator. A continuous signal audible to the fluoroscopist
shall indicate that the high level control is being employed.
(2)
Fluoroscopic Equipment Manufactured On or After May 19,
1995.
(a) Shall be equipped with
automatic exposure rate control if operable at any combination of tube
potential and current that results in an AKR greater than 44 mGy per minute
(five R/min exposure rate) at the measurement point specified in 105 CMR
120.405(C)(3). Provision for manual selection of technique factors may be
provided.
(b) Shall not be operable
at any combination of tube potential and current that will result in an AKR in
excess of 88 mGy per minute (ten R/min exposure rate) at the measurement point
specified in 105 CMR 120.405(C)(3).
(c) Exceptions:
1. For equipment manufactured prior to June
10, 2006, during the recording of images from a fluoroscopic image receptor
using photographic film or a video camera when the x-ray source is operated in
a pulsed mode.
2. For equipment
manufactured on or after June 10, 2006, during the recording of images from the
fluoroscopic image receptor for the purpose of providing the user with a
recorded image(s) after termination of the exposure. Such recording does not
include images resulting from a last-image-hold feature that are not
recorded.
3. When a mode of
operation has an optional high-level control and the control is activated, in
which case the equipment shall not be operable at any combination of tube
potential and current that will result in an AKR in excess of 176 mGy per
minute (20 R/min exposure rate) at the measurement point specified in 105 CMR
120.405(C)(3). Special means of activation of high-level controls shall be
required. The high-level control shall be operable only when continuous manual
activation is provided by the operator. A continuous signal audible to the
fluoroscopist shall indicate that the high-level control is employed.
(3) Compliance with the
requirements of 105 CMR 120.405(C) shall be determined as follows:
(a) If the source is below the table, the AKR
shall be measured one centimeter above the tabletop or cradle.
(b) If the source is above the table, the AKR
shall be measured at 30 centimeters above the tabletop with the end of the
beam-limiting device or spacer positioned as closely as possible to the point
of measurement.
(c) For a C-arm
type of fluoroscope, the AKR shall be measured 30 centimeters from the input
surface of the fluoroscopic imaging assembly, with the source positioned at any
available SID, provided that the end of the beam-limiting device or spacer is
no closer than 30 centimeters from the input surface of the fluoroscopic
imaging assembly;
(d) For a lateral
type fluoroscope, the air kerma rate shall be measured at a point 15
centimeters from the centerline of the x-ray table and in the direction of the
x-ray source with the end of the beam-limiting device or spacer positioned as
closely as possible to the point of measurement. If the tabletop is movable, it
shall be positioned as closely as possible to the lateral x-ray source, with
the end of the beam-limiting device or spacer no closer than 15 centimeters to
the centerline of the x-ray table.
(e) In a C-arm type of fluoroscope having an
SID less than 45 cm, the AKR shall be measured at the minimum SSD.
(4) The registrant of a facility
or responsible person at the facility shall have a qualified medical physicist
perform periodic measurement of AKR for both typical and maximum values as
follows:
(a) Such measurements shall be made
annually or after any maintenance of the system which might affect the
AKR;
(b) If the fluoroscope does
not display the AKR of the current patient in view of the operator when the
fluoroscopy trigger is depressed, results of these measurements shall be posted
where any fluoroscopist may have ready access to such results while using the
fluoroscope and in the record required in
105 CMR
120.403(A)(2)(b). The
measurement results shall be stated in coulombs per kilogram (roentgens) per
minute and include the technique factors used in determining such results. The
name of the individual performing the measurements and the date the
measurements were performed shall be included in the results;
(c) Conditions of periodic measurement of
typical AKR are as follows:
1. The measurement
shall be made under the conditions that satisfy the requirements of 105 CMR
120.405(C)(1)(c);
2. The kVp, mA,
and/or other selectable parameters shall be adjusted to those settings typical
of clinical use for an abdominal patient;
3. The x-ray system that incorporates
automatic Exposure rate control shall have sufficient
attenuative material placed in the useful beam to produce a milliamperage
and/or kilovoltage to satisfy the conditions of 105 CMR 120.405(C)(1)(e)3.; and
(d) Conditions of
periodic measurement of maximum AKR are as follows:
1. The measurement shall be made under the
conditions that satisfy the requirements of 105 CMR 120.405(C)(1)(c);
2. The kVp, mA and/or other selectable
parameters shall be adjusted to those settings which give the maximum
AKR;
3. The x-ray system(s) that
incorporates automatic exposure rate control shall have sufficient attentuative
material placed in the useful beam to produce the maximum AKR of the
system.
(D)
Barrier Transmitted Radiation
Rate Limits.
(1) The AKR due to
transmission through the primary protective barrier with the attenuation block
in the useful beam, combined with radiation from the image intensifier, if
provided, shall not exceed two milliroentgen (0.516 µC/kg) per hour at
ten centimeters from any accessible surface of the fluoroscopic imaging
assembly beyond the plane of the image receptor for each roentgen per minute of
AKR.
(2)
Measuring
Compliance of Barrier Transmission.
(a) The AKR due to transmission through the
primary protective barrier combined with radiation from the image intensifier
shall be determined by measurements averaged over an area of 100 square
centimeters with no linear dimension greater than 20 centimeters.
(b) If the source is below the tabletop, the
measurement shall be made with the input surface of the fluoroscopic imaging
assembly positioned 30 centimeters above the tabletop.
(c) If the source is above the tabletop and
the SID is variable, the measurement shall be made with the end of the
beam-limiting device or spacer as close to the tabletop as it can be placed,
provided that it shall not be closer than 30 centimeters.
(d) Movable grids and compression devices
shall be removed from the useful beam during the measurement.
(e) The attenuation block shall be positioned
in the useful beam ten centimeters from the point of measurement of AKR and
between this point and the input surface of the fluoroscopic imaging
assembly.
(E)
Indication of Potential and Current. During
fluoroscopy and cinefluorography the kV and the mA shall be continuously
indicated.
(F)
Source-to-skin Distance.
(1) Means shall be provided to limit the
source-skin distance to not less than 38 cm on stationary fluoroscopes and to
not less than 30 cm on mobile and portable fluoroscopes. In addition, for
fluoroscopes intended for specific surgical application that would be
prohibited at the source-skin distances specified in 105 CMR 120.405(D)(1),
provisions may be made for operating at shorter source-skin distances but in no
case less than 20 cm.
(2) For
stationary, mobile, or portable C-arm fluoroscopic systems manufactured on or
after June 10, 2006, having a maximum source-image receptor distance of less
than 45 cm, means shall be provided to limit the source-skin distance to not
less than 19 cm. Such systems shall be labeled for extremity use only. In
addition, for those systems intended for specific surgical application that
would be prohibited at the source-skin distance specified in 105 CMR
120.405(F)(2), provisions may be made for operation at shorter source-skin
distances but in no case less than ten cm.
(G)
Fluoroscopic
Timer.
(1)
Fluoroscopic Equipment Manufactured Before June 10,
2006:
(a) Means shall be
provided to preset the cumulative on-time of the fluoroscopic x-ray tube. The
maximum cumulative time of the timing device shall not exceed five minutes
without resetting.
(b) A signal
audible to the fluoroscopist shall indicate the completion of any preset
cumulative on-time. Such signal shall continue to sound while x-rays are
produced until the timing device is reset.
(2) For x-ray controls manufactured on or
after June 10, 2006, there shall be provided for each fluoroscopic tube:
(a) A display of the fluoroscopic irradiation
time at the fluoroscopist's working position. This display shall function
independently of the audible signal described in 105 CMR 120.405(G)(2). The
following requirements apply:
1. When the
x-ray tube is activated, the fluoroscopic irradiation time in minutes and
tenths of minutes shall be continuously displayed and updated at least once
every six seconds.
2. The
fluoroscopic irradiation time shall also be displayed within six seconds of
termination of an exposure and remain displayed until reset.
3. Means shall be provided to reset the
display to zero prior to the beginning of a new examination or
procedure.
(b) A signal
audible to the fluoroscopist shall sound for each passage of five minutes of
fluoroscopic irradiation time during an examination or procedure. The signal
shall sound until manually reset or, if automatically reset, for at least two
seconds.
(H)
Control of Scattered Radiation.
(1) Fluoroscopic table designs when combined
with procedures utilized shall be such that no unprotected part of any staff or
ancillary individual's body shall be exposed to unattenuated scattered
radiation which originates from under the table. The attenuation required shall
be not less than 0.25 millimeter lead equivalent.
(2) Equipment configuration when combined
with procedures shall be such that no portion of any staff or ancillary
individual's body, except the extremities, shall be exposed to the unattenuated
scattered radiation emanating from above the tabletop unless that individual:
(a) Is at least 120 centimeters from the
center of the useful beam; or
(b)
The radiation has passed through not less than 0.25 millimeter lead equivalent
material including, but not limited to, drapes, Bucky-slot cover panel, or
self-supporting curtains, in addition to any lead equivalency provided by the
protective apron referred to in
105 CMR
120.403(A)(1)(e).
(3) The Agency may grant
exemptions to 105 CMR 120.405(H)(2) where a sterile field will not permit the
use of the normal protective barriers. Where the use of prefitted sterilized
covers for the barriers is practical, the Agency shall not permit such
exemption. See 105
CMR 120.423: Appendix D for
a suggested list of fluoroscopic procedures where such exemptions will be
automatically granted.
(I)
Radiation Therapy Simulation
Systems. Radiation therapy simulation systems shall be exempt from
all the requirements of 105 CMR 120.405(A), (C), (D) and (G) provided that:
(1) Such systems are designed and used in
such a manner that no individual other than the patient is in the x-ray room
during periods of time when the system is producing x-rays; and,
(2) Systems which do not meet the
requirements of 105 CMR 120.405(G) are provided with a means of indicating the
cumulative time that an individual patient has been exposed to x-rays.
Procedures shall require in such cases that the timer be reset between
examinations.
(J)
Spot film Exposure Reproducibility. Fluoroscopic
systems equipped with spot film (radiographic) modes shall meet the exposure
reproducibility requirements when operating in the spot film mode.
(K)
Operator
Qualifications.
(1) The
Registrant of a facility shall ensure that only the following health care
providers shall be allowed to operate fluoroscopic x-ray systems:
(a) Licensed physicians who are
board-certified in radiology;
(b)
Licensed physicians who are not board-certified in radiology provided that they
have been trained in the following subjects:
1. Principles and operation of the
fluoroscopic x-ray system;
2.
Biological effects of x-ray;
3.
Principles of radiation protection;
4. Fluoroscopic outputs;
5. High level control options;
6. Dose reduction techniques for fluoroscopic
x-ray systems; and
7. Application
requirements of
105
CMR 120.000.
(c) Radiologic technologists who are licensed
in accordance with
105 CMR 125.000 and have
been trained in the safe use of fluoroscopic x-ray systems; and
(d) Physician assistants who are licensed in
accordance with M.G.L. c. 112, § 9I, and
263 CMR 3.00:
Registration of Individual Physician Assistants, and who meet
the requirements of 105 CMR 120.405(K)(2).
(2) The Registrant of a facility shall ensure
that a physician assistant delegated the performance of specified fluoroscopic
procedures by a supervising physician has submitted documentation of the
following to the facility:
(a) Successful
completion of the education and clinical training specified in 105 CMR
120.405(K)(3) offered by an approved provider;
(b) a passing score on an examination offered
by the American Registry of Radiologic Technologists (ARRT) or equivalent exam
approved by the Agency covering the educational and clinical requirements
specified in 105 CMR 120.405(K)(3);
(c) a written and signed statement from the
physician assistant's supervising physician, who meets the requirements of 105
CMR 120.405(K)(1)(a) or (b), verifying the physician assistant's competency to
perform specified fluoroscopic procedures; and
(d) a written practice agreement between the
physician assistant and his or her supervising physician as set forth in
regulations of the Board of Registration in Medicine at
243 CMR 2.08
and of the Board of Registration of Physician Assistants in
263 CMR 5.00: Scope of
Practice and Employment of Physician Assistants.
(3) The education and clinical training
required by 105 CMR 120.405(K)(2)(a) shall consist of the following:
(a) Didactic Content
1. Digital image acquisition and
display;
2. Contrast
media;
3. Fluoroscopic unit
operation and safety;
4. Image
analysis;
5. Radiation
biology;
6. Radiation production
and characteristics; and
7.
Radiation protection.
(b) Clinical Component
1. Clinical competency requirement: 40
clinical hours performing fluoroscopic procedures in a fluoroscopic suite under
the direct supervision of a physician who meets the requirements of 105 CMR
120.405(K)(1)(a) or (b), a medical physicist, or a radiography educator.
"Direct supervision," as used in 105 CMR 120.405(K)(3), means physically
present where the fluoroscopic procedure is being performed and immediately
available and able to provide assistance and direction throughout the
procedure;
2. Fluoroscopic device
orientation: safe and proper manipulation of the fluoroscopic device.
(4) The Registrant of
the facility and/or responsible person at the facility shall maintain all
records relating to compliance with the education and clinical training
requirements for the current year and the previous four years.
(5) The facility shall establish policies and
procedures for limiting the performance of fluoroscopic procedures to only
those health care providers who have met the requirements of 105 CMR 120.405(K)
and who have been granted privileges for the use of fluoroscopy based on their
demonstrated competency in the performance of fluoroscopic
procedures.
(6) The Registrant of
the facility shall ensure that all physicians who are not board certified in
radiology and who perform fluoroscopic procedures complete two hours of
training in Radiation Safety/Radiation Protection on an annual basis, and that
all physicians who are not board certified in radiology who supervise the
performance of fluoroscopic procedures complete a total of four hours of
Radiation Safety/Radiation Protection training on an annual basis. The facility
shall maintain all records relating to compliance with this training
requirement for the current year and the previous four years.
(7) The Registrant of a facility shall ensure
that licensed radiologic technologists and licensed physician assistants who
perform fluoroscopic procedures have satisfied all related continuing education
requirements as required by their respective licensing boards, and shall
maintain records documenting completion of such continuing education
requirements by radiologic technologists and physician assistants for five
years.
(8) In addition to any other
reporting requirements, the facility shall immediately, and no later than 24
hours after discovery, report to the Agency any incident at the facility
involving fluoroscopic procedures that seriously affects the health and safety
of a patient or that causes serious physical injury to a patient due to
radiation exposure.
(9) Nothing in
105 CMR 120.405(K) shall prohibit nurse practitioners from practicing within
their lawful scope of practice, including functioning as first assistants
during cardiac catheterization procedures in accordance with
105
CMR 130.900: Standards for Operation
of Hospital-based Cardiac Catheterization Services, and the Board of
Registration in Nursing Advisory Ruling Number 0201, Nurse Practitioner
as First Assistant in Cardiac Catherization, provided that the
physician who is the primary operator, as defined in
105 CMR 130.910, is
qualified to operate fluoroscopic x-ray systems pursuant to 105 CMR
120.405(K)(1)(a) or (b).
(L)
Patient Dose
Evaluation.
(1) Each facility
performing fluoroscopically-guided interventional and CT fluoro procedures
shall conduct patient dose evaluation for any procedure that has a reasonable
probability of resulting in a deterministic injury as further defined in 105
CMR 120.405(L)(5).
(2) Records
documenting that policies and procedures have been developed to determine that
those procedures that have a potential to result in patient doses exceeding the
threshold for injury have been established to reduce the probability of such
exposures and that appropriate action occurs for patients receiving doses that
warrant follow-up.
(3) The facility
shall have a patient dose monitoring procedures in place. When the fluoroscopy
unit is equipped with an Air-Kerma dose readout, the recording of this value
shall suffice as a patient dose record.
(4) The facility shall document in the
patient's medical record an estimate of the absorbed dose to the
skin.
(5) Any cumulative absorbed
dose to the skin equal to or greater than 2 Gy (200 rads) shall be noted in the
patient's medical record and reviewed by the Radiation Safety Committee.
(6) Each facility that use
fluoroscopic x-ray systems shall maintain a record of the cumulative
fluoroscopic exposure time used and the number of spot films for each
examination. This record shall indicate patient identification, type of
examination, date of examination, and operator's name. The record shall be
maintained for five years.
(M)
Equipment
Operation.
(1) Radiological
technology students shall not be allowed to operate fluoroscopic x-ray systems
unless directly supervised by a licensed practitioner of the healing arts or a
licensed Radiological Technologist.
(2) Overhead fluoroscopy shall not be used as
a positioning tool for general purpose radiographic examinations.
(N)
Mini-C-Arms. 105 CMR 120.405 includes
Mini-C-Arms.